BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

139 related articles for article (PubMed ID: 29332874)

  • 21. Danazol for the treatment of thrombocytopenia in patients with myelodysplastic syndrome.
    Chan G; DiVenuti G; Miller K
    Am J Hematol; 2002 Nov; 71(3):166-71. PubMed ID: 12410570
    [TBL] [Abstract][Full Text] [Related]  

  • 22. [Myelodysplastic syndrome accompanied by Evans syndrome].
    Takezako N; Shikai T; Tanimura A; Inokuchi C; Yamagata N; Masaki N; Miwa A
    Rinsho Ketsueki; 2003 Jun; 44(6):396-400. PubMed ID: 12884819
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Platelet transfusion therapy in thrombocytopaenia of haematologic malignancies.
    Charak BS; Rao K; Parikh PM; Rawat RS; Nair CN; Advani SH
    J Assoc Physicians India; 1989 Mar; 37(3):201-3. PubMed ID: 2768161
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Inherited platelet disorders : Management of the bleeding risk.
    Dupuis A; Gachet C
    Transfus Clin Biol; 2018 Sep; 25(3):228-235. PubMed ID: 30077511
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Conjunctival bleeding in Osler's disease with associated platelet dysfunction. A case report.
    Pandolfi M; Ehinger B
    Acta Ophthalmol (Copenh); 1978 Feb; 56(1):75-82. PubMed ID: 580338
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Platelet function in the myelodysplastic syndromes.
    Mittelman M; Zeidman A
    Int J Hematol; 2000 Feb; 71(2):95-8. PubMed ID: 10745619
    [TBL] [Abstract][Full Text] [Related]  

  • 27. [Retrospective analysis of hemotherapy support in 226 cases of myelodysplastic syndromes].
    Rubio-Félix D; Franco E; Giraldo P; Gimeno J; Cuesta I; Giralt M
    Sangre (Barc); 1994 Apr; 39(2):117-20. PubMed ID: 8059289
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Characterization of a novel bleeding disorder with isolated prolonged bleeding time and deficiency of platelet microvesicle generation.
    Castaman G; Yu-Feng L; Battistin E; Rodeghiero F
    Br J Haematol; 1997 Mar; 96(3):458-63. PubMed ID: 9054648
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Correction of platelet dysfunction and bleeding in cyanotic congenital heart disease by simple red cell volume reduction.
    Maurer HM; McCue CM; Robertson LW; Haggins JC
    Am J Cardiol; 1975 Jun; 35(6):831-5. PubMed ID: 48335
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Massive platelet transfusion is a rapidly effective emergency treatment in patients with refractory autoimmune thrombocytopenia.
    Salama A; Kiesewetter H; Kalus U; Movassaghi K; Meyer O
    Thromb Haemost; 2008 Nov; 100(5):762-5. PubMed ID: 18989518
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Thrombocytopenia in MDS: epidemiology, mechanisms, clinical consequences and novel therapeutic strategies.
    Li W; Morrone K; Kambhampati S; Will B; Steidl U; Verma A
    Leukemia; 2016 Mar; 30(3):536-44. PubMed ID: 26500138
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Health care utilization and risk of infection and bleeding among patients with myelodysplastic syndromes with/without transfusions, and with/without active therapy.
    Smith BD; Mahmoud D; Dacosta-Byfield S; Rosen VM
    Leuk Lymphoma; 2014 May; 55(5):1119-25. PubMed ID: 23841504
    [TBL] [Abstract][Full Text] [Related]  

  • 33. [Therapeutic possibilities in the management of gastrointestinal bleeding in thrombocytopenic patients].
    Gurzó M; Varga G; Dobos K; Náfrádi J; Petri A
    Orv Hetil; 1994 Apr; 135(15):805-8. PubMed ID: 8177598
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Resolution of chronic severe refractory thrombocytopenia after treatment of hypothyroidism.
    Bowles KM; Turner GE; Wimperis JZ
    J Clin Pathol; 2004 Sep; 57(9):995-6. PubMed ID: 15333667
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Severe gingival bleeding in a myelodysplastic patient: management and outcome.
    Pereira CM; Gasparetto PF; Coracin FL; Marquês JF; Lima CS; Corrêa ME
    J Periodontol; 2004 Mar; 75(3):483-6. PubMed ID: 15088888
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Severe acquired platelet dysfunction because of primary myelofibrosis with full functional and morphological recovery after allogeneic hematopoietic cell transplantation.
    Linnik YA; Salvatore LT; Lowrey CH; Ornstein DL
    Blood Coagul Fibrinolysis; 2019 Dec; 30(8):419-422. PubMed ID: 31483321
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Investigation of coronary artery bypass grafting for a patient with myelodysplastic syndrome.
    Miyagi Y; Yamauchi S; Suzuki S; Kitagawa A; Masaki Y; Gomibuchi M; Tanaka S
    Ann Thorac Cardiovasc Surg; 2001 Aug; 7(4):250-3. PubMed ID: 11578269
    [TBL] [Abstract][Full Text] [Related]  

  • 38. [Myelodysplastic syndrome with rapid disease progression after withdrawal of treatment with azacitidine].
    Ueda H; Yoshida M; Kanashima H; Nakao T; Sugiyama H; Yamane T
    Gan To Kagaku Ryoho; 2014 Jul; 41(7):875-7. PubMed ID: 25131875
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Platelet adhesion defect in type I Gaucher Disease is associated with a risk of mucosal bleeding.
    Spectre G; Roth B; Ronen G; Rosengarten D; Elstein D; Zimran A; Varon D; Revel-Vilk S
    Br J Haematol; 2011 May; 153(3):372-8. PubMed ID: 21401572
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Acquired platelet dysfunction with eosinophilia in children in the south of Thailand.
    Laosombat V; Wongchanchailert M; Sattayasevana B; Kietthubthew S; Wiriyasateinkul A
    Platelets; 2001 Feb; 12(1):5-14. PubMed ID: 11281630
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.